Mednet Logo
HomeRadiation Oncology
Radiation Oncology

Radiation Oncology

Expert insights on radiation treatment planning, techniques, toxicity management, and multimodal cancer care.

Recent Discussions

How many PTVs and what doses do you utilize for a cT3N0M0 squamous cell carcinoma of the larynx receiving definitive concurrent chemoradiation?

2
1 Answers

Mednet Member
Mednet Member
Radiation Oncology · University of Texas MD Anderson Cancer Center

I typically think of 2 targets - a clinical target and a subclinical target. Whether one wants to divide the subclinical target into 2 targets - an intermediate and lower risk target is an option, but whether it is an absolute is a matter for debate. Traditional treatment was large fields followed b...

Should a formal radiology year(s) be added to the radiation oncology residency training program given the number and increasing modalities used for target delineation and treatment planning?

4
3 Answers

Mednet Member
Mednet Member
Radiation Oncology · Coastal Radiation Oncology

As I close in on the end of my career, I must disagree with this idea! I’m sure we all are greatly impressed by the clinical acumen of our fourth-year medical students but that is not enough clinical training. My three-year medical residency taught me how to be a DOCTOR, my radiation oncology reside...

Do you require a biopsy prior to SBRT for pulmonary metastases from oligometastatic disease?

3 Answers

Mednet Member
Mednet Member
Radiation Oncology · Rutgers Robert Wood Johnson Medical School

A biopsy of a lung mass can be central to the appropriate management of your case. Some of the risk factors for GI cancers and lung cancers are the same, ie smoking. We have had several patients with anal cancers who have subsequently been found to have synchronous lung cancers with different histol...

How were decisions made about what dose constraints to use in the recent RTOG protocols for lung SBRT?

1 Answers

Mednet Member
Mednet Member
Radiation Oncology · Cleveland Clinic

This is a question that is frequently and appropriately asked by SBRT beginners and experienced practitioners. The history of SBRT in that regard replicates much of the historic experience in RT which is that the data generated from treating the patients generated the constraints, so to speak, as op...

Do you cover vasogenic edema surrounding the GTV when treating brain metastasis with SRS?

1 Answers

Mednet Member
Mednet Member
Radiation Oncology · Johns Hopkins

The edema is not usually covered for brain metastasis during SRS. These changes are likely reactive changes and less likely to represent infiltrative disease, unlike in primary CNS tumors.

What is the appropriate dose for a patient with recurrent vulva VIN III?

1 Answers

Mednet Member
Mednet Member
Radiation Oncology · Varian Medical Systems/Allegheny health network

I have never treated VIN III by itself without any evidence of invasion, although I have had patients with diffuse VIN with invasion who responded well to RT with regression of both invasive disease and VIN changes. Dose is hard to answer but all these pts get at least 50Gy for invasive disease.

In treating with total body irradiation, how should the lung blocks be drawn and what dose should the lung receive?

1
1 Answers

Mednet Member
Mednet Member
Radiation Oncology · Northwestern University

I draw lung blocks 1 cm. insde the edge of peripheral lung including apex of the lung . The doses are usally 5% less than the prscribed doses to central axis . The typical TBI schedule as a conditioning regimen for BMT is 150 cGy BID for 1200 cGy . Bharat

What is the role in your clinic for chest imaging in head and neck cancer patients who are free of local disease 1+ years after treatment?

1 Answers

Mednet Member
Mednet Member
Radiation Oncology · University of Iowa

Our multidisciplinary team continues to discuss this controversial area. We tend to obtain annual low-dose non-contrast CT chest scans for 5 years in patients with N2-N3 disease regardless of smoking status, if they would be healthy enough to undergo therapy for metastatic disease. In current/former...

How do you contour distal esophageal cancer in the postop setting after Ivor-Lewis pT3N3 (perigastric and periesophageal LN)?

1
1 Answers

Mednet Member
Mednet Member
Radiation Oncology · Rutgers Robert Wood Johnson Medical School

This case is a tough one--bulky disease at the junction of the esophagus and stomach so both sets of regional lymph nodes are involved. The Ivor-Lewis or transthoracic approach means that the anastomosis between remaining esophagus and stomach is located in the chest.The anastomoses need to be inclu...

If one decides to use a mpMRI to stage a pt with low-risk prostate cancer, how do you work up a focal lesion suspicious for higher grade GS 7-10 disease?

1 Answers

Mednet Member
Mednet Member
Radiation Oncology · UCLA | VA Greater Los Angeles Healthcare System

Even though modern mpMRI is sensitive (>90%) at detecting occult GS ≥4+3 cancers that are missed by blind systematic TRUS biopsies, it is not 100% specific. Almost all radiologists will occasionally over-call a radiographic abnormality when it is still only GS 6. When decisions to be made from this ...